Agenda - PDCO agenda of the 25-28 June 2024 meeting
Submitted by Anonymous (not verified) on 25 June 2024 - 15:45
Agenda - PDCO agenda of the 25-28 June 2024 meeting
Veterinary medicines European public assessment report (EPAR): Semintra, telmisartan, Status: Authorised
Submitted by Anonymous (not verified) on 25 June 2024 - 15:30
Veterinary medicines European public assessment report (EPAR): Semintra, telmisartan, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Apoquel, oclacitinib maleate, Status: Authorised
Submitted by Anonymous (not verified) on 25 June 2024 - 15:01
Veterinary medicines European public assessment report (EPAR): Apoquel, oclacitinib maleate, Status: Authorised
Nilotinib hard capsules 50, 150 and 200 mg product-specific bioequivalence guidance
Submitted by Anonymous (not verified) on 25 June 2024 - 14:05
Nilotinib hard capsules 50, 150 and 200 mg product-specific bioequivalence guidance
Methylphenidate, prolonged-release tablet 18 mg, 27 mg, 36 mg and 54 mg and modified release capsule 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg and 60 mg product-specific bioequivalence guidance
Submitted by Anonymous (not verified) on 25 June 2024 - 14:03
Methylphenidate, prolonged-release tablet 18 mg, 27 mg, 36 mg and 54 mg and modified release capsule 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg and 60 mg product-specific bioequivalence guidance
Management Board meeting dates 2025-2026
Submitted by Anonymous (not verified) on 25 June 2024 - 10:17
Management Board meeting dates 2025-2026
Outcome of written procedures finalised during the period from 12 March to 03 June 2024
Submitted by Anonymous (not verified) on 25 June 2024 - 10:12
Outcome of written procedures finalised during the period from 12 March to 03 June 2024
Webinar for industry and contract research organisations (CROs) on revised Environmental Risk Assessment (ERA) guideline for human medicinal products, Online, European Medicines Agency, Amsterdam, the Netherlands, 26 June 2024
Submitted by Anonymous (not verified) on 25 June 2024 - 10:10
Webinar for industry and contract research organisations (CROs) on revised Environmental Risk Assessment (ERA) guideline for human medicinal products, Online, European Medicines Agency, Amsterdam, the Netherlands, 26 June 2024
Overview of comments received on draft qualification opinion for Centiloid measure of Amyloid PET to quantify brain amyloid deposition
Submitted by Anonymous (not verified) on 25 June 2024 - 8:43
Overview of comments received on draft qualification opinion for Centiloid measure of Amyloid PET to quantify brain amyloid deposition
Qualification opinion for Centiloid measure of Amyloid PET to quantify brain amyloid deposition
Submitted by Anonymous (not verified) on 25 June 2024 - 8:42
Qualification opinion for Centiloid measure of Amyloid PET to quantify brain amyloid deposition